Protech Home Medical Announces Date and Time For Q1 Fiscal 2021 Quarterly Conference Call and Audio Webcast
February 22 2021 - 8:00AM
Protech Home Medical Corp. (the “
Company”)
(TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical
equipment industry, focused on end-to-end respiratory care, today
announced that it will host its Q1 Fiscal 2021 earnings conference
call and audio webcast on Tuesday, March 2, 2021 at 10:00 a.m.
(EST).
Conference Call Details:
Tuesday, March 2, 2021 at 10:00 a.m. (EST).
Canada/US Toll Free: 1 (800) 319 4610International: 1 (604) 638
5340
Audio Webcast Details:
The live audio webcast can be found on the investor section of
the Company’s website through the following
link:https://protechhomemedical.com/conference_calls
“As we work towards completion of our planned
NASDAQ listing, and execute on our comprehensive capital markets
strategy for 2021 and beyond, we have decided Q1 Fiscal 2021 is the
optimal time to begin reporting our financial results in U.S.
dollars. This change will allow our investors to make constant
currency comparisons on a go forward basis, thus removing the FX
impact from our financial reporting,” said Greg Crawford, Chairman
and CEO of Protech. “We are delighted to make this important change
to our financial reporting presentation, completing another
milestone in our company’s evolution. As a whole we have grown into
a significant regional respiratory care provider in the United
States and are knocking on the door of becoming a national
provider, as we leverage our significant infrastructure and seek to
add turn-key respiratory home care operators to our family of
companies. We have an exceptional pipeline of potential acquisition
targets, which we expect to keep us very busy over the months to
come.”
The listing of the Company’s common shares on
the NASDAQ Capital Market (“NASDAQ”) remains
subject to the approval of the listing application by NASDAQ and
the satisfaction of all applicable listing and regulatory
requirements, as well as effectiveness of the registration
statement with the United States Securities and Exchange Commission
(the “SEC”).
ABOUT PROTECH HOME MEDICAL
The Company provides in-home monitoring and
disease management services including end-to-end respiratory
solutions for patients in the United States healthcare market. It
seeks to continue to expand its offerings to include the management
of several chronic disease states focusing on patients with heart
or pulmonary disease, sleep disorders, reduced mobility and other
chronic health conditions. The primary business objective of the
Company is to create shareholder value by offering a broader range
of services to patients in need of in-home monitoring and chronic
disease management. The Company’s organic growth strategy is to
increase annual revenue per patient by offering multiple services
to the same patient, consolidating the patient’s services and
making life easier for the patient.
Forward-Looking Statements
Certain statements contained in this press
release constitute "forward-looking information" as such term is
defined in applicable Canadian securities legislation. The
words "may", "would", "could", "should", "potential", "will",
"seek", "intend", "plan", "anticipate", "believe", "estimate",
"expect" and similar expressions as they relate to the Company,
including: the potential listing of Protech’s common shares on
NASDAQ and its plans to file a Registration Statement with the
SEC; and Protech expecting to be very busy with acquisitions over
the months to come; are intended to identify forward-looking
information. All statements other than statements of historical
fact may be forward-looking information. Such statements reflect
the Company's current views and intentions with respect to
future events, and current information available to the Company,
and are subject to certain risks, uncertainties and assumptions,
including: failure to get the necessary approval to list on
Nasdaq; and the Company successfully identified, negotiating and
completing additional acquisitions, including accretive
acquisitions. Many factors could cause the actual results,
performance or achievements that may be expressed or implied by
such forward-looking information to vary from those described
herein should one or more of these risks or uncertainties
materialize. Examples of such risk factors include, without
limitation: credit; market (including equity, commodity, foreign
exchange and interest rate); liquidity; operational (including
technology and infrastructure); reputational; insurance;
strategic; regulatory; legal; environmental; capital adequacy; the
general business and economic conditions in the regions in
which the Company operates; the ability of the Company to execute
on key priorities, including the successful completion of
acquisitions, business retention, and strategic plans and to
attract, develop and retain key executives; difficulty
integrating newly acquired businesses; the ability to implement
business strategies and pursue business opportunities; low profit
market segments; disruptions in or attacks (including
cyber-attacks) on the Company's information technology, internet,
network access or other voice or data communications systems or
services; the evolution of various types of fraud or other
criminal behavior to which the Company is exposed; the failure
of third parties to comply with their obligations to the Company
or its affiliates; the impact of new and changes to, or
application of, current laws and regulations; decline of
reimbursement rates; dependence on few payors; possible new drug
discoveries; a novel business model; dependence on key
suppliers; granting of permits and licenses in a highly regulated
business; the overall difficult litigation environment,
including in the U.S.; increased competition; changes in foreign
currency rates; increased funding costs and market volatility
due to market illiquidity and competition for funding; the
availability of funds and resources to pursue operations;
critical accounting estimates and changes to accounting standards,
policies, and methods used by the Company; the occurrence of
natural and unnatural catastrophic events and claims resulting
from such events; and risks related to COVID-19 including various
recommendations, orders and measures of governmental
authorities to try to limit the pandemic, including travel
restrictions, border closures, non-essential business
closures, quarantines, self-isolations, shelters-in-place and
social distancing, disruptions to markets, economic activity,
financing, supply chains and sales channels, and a deterioration
of general economic conditions including a possible national
or global recession; as well as those risk factors discussed or
referred to in the Company’s disclosure documents filed with
the securities regulatory authorities in certain provinces of
Canada and available at www.sedar.com. Should any factor affect
the Company in an unexpected manner, or should assumptions
underlying the forward-looking information prove incorrect, the
actual results or events may differ materially from the
results or events predicted. Any such forward-looking information
is expressly qualified in its entirety by this cautionary
statement. Moreover, the Company does not assume responsibility
for the accuracy or completeness of such forward-looking
information. The forward-looking information included in this
press release is made as of the date of this press release and
the Company undertakes no obligation to publicly update or
revise any forward-looking information, other than as required by
applicable law.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
For further information please visit our website
at www.protechhomemedical.com, or contact:
Cole StevensVP of Corporate Development Protech
Home Medical Corp.859-300-6455cole.stevens@myphm.com
Gregory CrawfordChief Executive OfficerProtech
Home Medical Corp.859-300-6455investorinfo@myphm.com
Protech Home Medical (TSXV:PTQ)
Historical Stock Chart
From Oct 2024 to Nov 2024
Protech Home Medical (TSXV:PTQ)
Historical Stock Chart
From Nov 2023 to Nov 2024
